收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Revenues | revenue | 1.05B | 2.54% |
| Gross profit | profit | 586.40M | 1.02% |
| Cost of revenues | cost | 321.90M | 6.91% |
| Amortization of acquired intangible assets | cost | 41.00M | -10.87% |
| Interest income | revenue | 19.70M | -18.60% |
| Other income | revenue | 600000 | -97.50% |
| Income from operations | profit | 237.00M | 3.13% |
| Operating expenses | cost | 349.40M | -0.37% |
| Aggregate | revenue | 257.30M | -7.45% |
| Selling and marketing | cost | 154.90M | -6.74% |
| General and administrative | cost | 127.80M | 10.46% |
| Research and development | cost | 60.50M | 0.33% |
| Restructuring charges | cost | 3.90M | 0.00% |
| Amortization of acquired intangible assets | cost | 2.30M | -51.06% |
| Income before income taxes | profit | 229.70M | -7.19% |
| Interest expense, nonoperating | cost | 27.60M | -9.51% |
| Net income (loss) | profit | 179.10M | -10.90% |
| Provision for income taxes | cost | 50.60M | 8.82% |
| Segment | Value | YoY |
|---|---|---|
| Diagnostics | 464.40M | -1.32% |
| Breast Health | 375.90M | 1.84% |
| Gyn Surgical | 180.80M | 8.72% |
| Skeletal Health | 26.70M | 68.99% |
| Segment | Value | YoY |
|---|---|---|
| UNITED STATES | 773.50M | 2.06% |
| Europe | 161.60M | 8.53% |
| Asia Pacific | 56.70M | -5.18% |
| Rest of World | 56.00M | 1.45% |
| Segment | Value | YoY |
|---|---|---|
| Molecular Diagnostics | 329.20M | -3.49% |
| Breast Imaging | 280.00M | -0.57% |
| Cytology & Perinatal | 126.80M | 1.12% |
| Interventional Breast Solutions | 95.90M | 9.60% |
| Blood Screening | 8.40M | 104.88% |
| Others | 207.50M | 13.95% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and cash equivalents | assets | 2.17B | |
| Inventory | assets | 688.50M | |
| Accounts receivable, less reserves | assets | 584.20M | |
| Short-term investments | assets | 196.70M | |
| Prepaid expenses and other current assets | assets | 176.00M | |
| Prepaid income taxes | assets | 30.00M | |
| Total current assets | assets | 3.84B | |
| Goodwill | assets | 3.65B | |
| Other assets | assets | 576.50M | |
| Property, plant and equipment, net | assets | 568.30M | |
| Intangible assets, net | assets | 547.30M | |
| Identifiable assets | assets | 9.18B | |
| Long-term debt, net of current portion | liabilities | 2.50B | |
| Total current liabilities | liabilities | 951.30M | |
| Other long-term liabilities | liabilities | 419.00M | |
| Deferred income tax liabilities | liabilities | 41.90M | |
| Deferred revenue, net of current portion | liabilities | 12.40M | |
| Finance lease obligations, net of current portion | liabilities | 8.10M | |
| Total stockholders’ equity | equity | 5.25B | |
| Treasury stock, value | equity | 4.61B | |
| Accumulated other comprehensive loss | equity | 94.80M | |
| Accrued expenses | liabilities | 570.00M | |
| Accounts payable | liabilities | 201.10M | |
| Deferred revenue | liabilities | 170.90M | |
| Long-term debt, current maturities | liabilities | 5.80M | |
| Finance lease obligations | liabilities | 3.50M | |
| Aggregate | equity | 9.95B | |
| Additional paid-in-capital | equity | 6.36B | |
| Retained earnings | equity | 3.59B | |
| Common stock, $0.01 par value – 750,000 shares authorized; 302,940 and 302,438 shares issued, respectively | equity | 3.00M |
| Item | Value |
|---|---|
| Net income (loss) | 179.10M |
| Amortization of acquired intangible assets | 43.30M |
| Stock-based compensation expense | 26.90M |
| Depreciation | 26.30M |
| Increase (decrease) in accounts receivable | 18.00M |
| Accounts payable | 7.80M |
| Other noncash income (expense) | 6.60M |
| Increase (decrease) in prepaid taxes | 3.20M |
| Deferred income taxes | -1.10M |
| Increase (decrease) in inventories | -8.60M |
| Accrued expenses and other liabilities | -17.30M |
| Increase (decrease) in prepaid expense and other assets | -25.10M |
| Deferred revenue | -29.20M |
| Item | Value |
|---|---|
| Maturities of available-for-sale securities | 48.00M |
| Payment for (proceeds from) other investing activity | -1.00M |
| Payments to acquire property, plant, and equipment | -14.70M |
| Payments to manufacture equipment under customer usage agreements | -20.40M |
| Strategic investments | -24.00M |
| Item | Value |
|---|---|
| Proceeds under employee stock plans | 8.30M |
| Payments under finance lease obligations | -900000 |
| Payment for tax withholding related to vested and released restricted stock units | -18.10M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 1.96B |
| Cash and cash equivalents, end of period | 2.17B |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图,与现金流量表瀑布图,一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持